ArticleGastroenterology & hepatology2016

The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature.

Yecheskel Schneider et al.PubMed ↗Full text ↗

No numbers read from the abstract.